BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON: Form 990, tax year 2016

View the entire original 990 at ProPublica ↗

Organization: BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON (EIN 91-0653422)
Tax period: 2016-01-01 to 2016-12-31
Filed: 2017-11-12
IRS object ID: 201703169349300425
Schema version: 2016v3.0
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule C
Schedule D
Schedule F
Schedule I
Schedule J
Schedule K
Schedule O
Schedule R
Affiliated Group Schedule

Return header ReturnHeader

Field	Value	IRS element (for citing)
Return	2017-11-12T02:08:39-00:00	ReturnTs
Tax Period End	2016-12-31	TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

Field	Value	IRS element (for citing)
Business Name Line1	KPMG LLP	BusinessNameLine1Txt

Preparer US Address PreparerUSAddress

Field	Value	IRS element (for citing)
Address Line1	1918 8th Avenue Suite 2900	AddressLine1Txt
City	Seattle	CityNm
State Abbreviation	WA	StateAbbreviationCd
ZIP	98101	ZIPCd

Field	Value	IRS element (for citing)
Return Type	990	ReturnTypeCd
Tax Period Begin	2016-01-01	TaxPeriodBeginDt

Filer Filer

Field	Value	IRS element (for citing)
EIN	910653422	EIN

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	Benaroya Research Institute at Virginia Mason	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Business Name Control	BENA	BusinessNameControlTxt
Phone	2063426500	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	1201 Ninth Avenue	AddressLine1Txt
City	Seattle	CityNm
State Abbreviation	WA	StateAbbreviationCd
ZIP	981012795	ZIPCd

Business Officer BusinessOfficerGrp

Field	Value	IRS element (for citing)
Person	Homer W Lane Jr	PersonNm
Person Title	Executive DirectorCFO	PersonTitleTxt
Signature	2017-10-23	SignatureDt
Discuss With Paid Preparer	Yes (true)	DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

Field	Value	IRS element (for citing)
Preparer Person	Sue Robison	PreparerPersonNm
Phone	2069134000	PhoneNum
Preparation	2017-10-23	PreparationDt

Filing Security Information FilingSecurityInformation

IP Address IPAddress

Field	Value	IRS element (for citing)
I Pv4 Address	204.147.223.1	IPv4AddressTxt

Field	Value	IRS element (for citing)
IP	2017-11-12	IPDt
IP Tm	21:01:41	IPTm
IP Timezone	PS	IPTimezoneCd
Filing License Type	P	FilingLicenseTypeCd
At Submission Creation Device Id	3583005D7428F592DDBE4235A0F9C55007128F9F	AtSubmissionCreationDeviceId
At Submission Filing Device Id	3583005D7428F592DDBE4235A0F9C55007128F9F	AtSubmissionFilingDeviceId

Field	Value	IRS element (for citing)
Tax	2016	TaxYr
Build TS	2017-02-10 21:41:12Z	BuildTS

Form 990 IRS990

Principal Ofcr Business Name PrincipalOfcrBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	Jane Buckner MD	BusinessNameLine1Txt

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	1201 Ninth Avenue	AddressLine1Txt
City	Seattle	CityNm
State Abbreviation	WA	StateAbbreviationCd
ZIP	98101	ZIPCd

Field	Value	IRS element (for citing)
Gross Receipts	$80,832,532	GrossReceiptsAmt
Group Return For Affiliates	false	GroupReturnForAffiliatesInd
Organization501c3	Yes (X)	Organization501c3Ind
Website Address	http://www.benaroyaresearch.org	WebsiteAddressTxt
Type Of Organization Corp	Yes (X)	TypeOfOrganizationCorpInd
Formation	1956	FormationYr
Legal Domicile State	WA	LegalDomicileStateCd
Activity Or Mission	To conduct and encourage high quality medical, surgical, and scientific research and research training in disease and problems of medical importance.	ActivityOrMissionDesc
Voting Members Governing Body	23	VotingMembersGoverningBodyCnt
Voting Members Independent	18	VotingMembersIndependentCnt
Total Employee	322	TotalEmployeeCnt
Total Volunteers	5	TotalVolunteersCnt
Total Gross UBI	$0	TotalGrossUBIAmt
PY Contributions Grants	$59,709,893	PYContributionsGrantsAmt
CY Contributions Grants	$71,346,495	CYContributionsGrantsAmt
PY Program Service Revenue	$7,021,290	PYProgramServiceRevenueAmt
CY Program Service Revenue	$8,553,010	CYProgramServiceRevenueAmt
PY Investment Income	-$107,705	PYInvestmentIncomeAmt
CY Investment Income	$394,767	CYInvestmentIncomeAmt
PY Other Revenue	$347,680	PYOtherRevenueAmt
CY Other Revenue	$347,680	CYOtherRevenueAmt
PY Total Revenue	$66,971,158	PYTotalRevenueAmt
CY Total Revenue	$80,641,952	CYTotalRevenueAmt
PY Grants And Similar Paid	$23,704,570	PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid	$29,786,250	CYGrantsAndSimilarPaidAmt
CY Benefits Paid To Members	$0	CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid	$25,752,883	PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid	$25,664,449	CYSalariesCompEmpBnftPaidAmt
CY Total Prof Fndrsng Expns	$0	CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense	$0	CYTotalFundraisingExpenseAmt
PY Other Expenses	$18,024,768	PYOtherExpensesAmt
CY Other Expenses	$19,506,635	CYOtherExpensesAmt
PY Total Expenses	$67,482,221	PYTotalExpensesAmt
CY Total Expenses	$74,957,334	CYTotalExpensesAmt
PY Revenues Less Expenses	-$511,063	PYRevenuesLessExpensesAmt
CY Revenues Less Expenses	$5,684,618	CYRevenuesLessExpensesAmt
Total Assets BOY	$85,438,161	TotalAssetsBOYAmt
Total Assets EOY	$91,306,270	TotalAssetsEOYAmt
Total Liabilities BOY	$45,136,173	TotalLiabilitiesBOYAmt
Total Liabilities EOY	$44,301,004	TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY	$40,301,988	NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY	$47,005,266	NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part III	Yes (X)	InfoInScheduleOPartIIIInd
Mission	See Schedule O.	MissionDesc
Significant New Program Srvc	false	SignificantNewProgramSrvcInd
Significant Change	false	SignificantChangeInd
Expense	$37,109,535	ExpenseAmt
Grant	$26,975,773	GrantAmt
Desc	Immune Tolerance Network Program. See Schedule O.	Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

Field	Value	IRS element (for citing)
Expense	$7,952,552	ExpenseAmt
Grant	$1,741,940	GrantAmt
Desc	Translational Program. See Schedule O.	Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

Field	Value	IRS element (for citing)
Expense	$6,870,598	ExpenseAmt
Grant	$754,214	GrantAmt
Desc	Diabetes Program. See Schedule O.	Desc

Field	Value	IRS element (for citing)
Total Other Prog Srvc Expense	$12,479,558	TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant	$314,323	TotalOtherProgSrvcGrantAmt
Total Other Prog Srvc Revenue	$8,553,010	TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses	$64,412,243	TotalProgramServiceExpensesAmt
Described In Section501c3	Yes (true)	DescribedInSection501c3Ind
Schedule B Required	Yes (true)	ScheduleBRequiredInd
Political Campaign Acty	false	PoliticalCampaignActyInd
Lobbying Activities	Yes (true)	LobbyingActivitiesInd
Subject To Proxy Tax	false	SubjectToProxyTaxInd
Donor Advised Fund	false	DonorAdvisedFundInd
Conservation Easements	false	ConservationEasementsInd
Collections Of Art	false	CollectionsOfArtInd
Credit Counseling	false	CreditCounselingInd
Temp Or Permanent Endowments	Yes (true)	TempOrPermanentEndowmentsInd
Report Land Building Equipment	Yes (true)	ReportLandBuildingEquipmentInd
Report Investments Other Sec	Yes (true)	ReportInvestmentsOtherSecInd
Report Program Related Invst	false	ReportProgramRelatedInvstInd
Report Other Assets	false	ReportOtherAssetsInd
Report Other Liabilities	false	ReportOtherLiabilitiesInd
Include FIN48 Footnote	false	IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt	Yes (true)	IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt	false	ConsolidatedAuditFinclStmtInd
School Operating	false	SchoolOperatingInd
Foreign Office	false	ForeignOfficeInd
Foreign Activities	Yes (true)	ForeignActivitiesInd
More Than5000 K To Org	Yes (true)	MoreThan5000KToOrgInd
More Than5000 K To Individuals	false	MoreThan5000KToIndividualsInd
Professional Fundraising	false	ProfessionalFundraisingInd
Fundraising Activities	false	FundraisingActivitiesInd
Gaming Activities	false	GamingActivitiesInd
Operate Hospital	false	OperateHospitalInd
Grants To Organizations	Yes (true)	GrantsToOrganizationsInd
Grants To Individuals	false	GrantsToIndividualsInd
Schedule J Required	Yes (true)	ScheduleJRequiredInd
Tax Exempt Bonds	Yes (true)	TaxExemptBondsInd
Invest Tax Exempt Bonds	false	InvestTaxExemptBondsInd
Escrow Account	false	EscrowAccountInd
On Behalf Of Issuer	Yes (true)	OnBehalfOfIssuerInd
Engaged In Excess Benefit Trans	false	EngagedInExcessBenefitTransInd
PY Excess Benefit Trans	false	PYExcessBenefitTransInd
Loan Outstanding	false	LoanOutstandingInd
Grant To Related Person	false	GrantToRelatedPersonInd
Business Rln With Org Mem	false	BusinessRlnWithOrgMemInd
Business Rln With Fam Mem	false	BusinessRlnWithFamMemInd
Business Rln With Officer Ent	false	BusinessRlnWithOfficerEntInd
Deductible Non Cash Contri	false	DeductibleNonCashContriInd
Deductible Art Contribution	false	DeductibleArtContributionInd
Terminate Operations	false	TerminateOperationsInd
Partial Liquidation	false	PartialLiquidationInd
Disregarded Entity	false	DisregardedEntityInd
Related Entity	Yes (true)	RelatedEntityInd
Related Organization Ctrl Ent	false	RelatedOrganizationCtrlEntInd
Transaction With Control Ent	false	TransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org	false	TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp	false	ActivitiesConductedPrtshpInd
Schedule O Required	Yes (true)	ScheduleORequiredInd
IRP Document	136	IRPDocumentCnt
IRP Document W2 G	0	IRPDocumentW2GCnt
Backup Wthld Compliance	Yes (true)	BackupWthldComplianceInd
Employee	322	EmployeeCnt
Employment Tax Returns Filed	Yes (true)	EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit	false	UnrelatedBusIncmOverLimitInd
Foreign Financial Account	false	ForeignFinancialAccountInd
Prohibited Tax Shelter Trans	false	ProhibitedTaxShelterTransInd
Taxable Party Notification	false	TaxablePartyNotificationInd
Nondeductible Contributions	false	NondeductibleContributionsInd
Quid Pro Quo Contributions	false	QuidProQuoContributionsInd
Form8282 Property Disposed Of	false	Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct	false	RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct	false	PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services	false	IndoorTanningServicesInd
Info In Schedule O Part VI	Yes (X)	InfoInScheduleOPartVIInd
Governing Body Voting Members	23	GoverningBodyVotingMembersCnt
Independent Voting Member	18	IndependentVotingMemberCnt
Family Or Business Rln	false	FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties	false	DelegationOfMgmtDutiesInd
Change To Org Documents	false	ChangeToOrgDocumentsInd
Material Diversion Or Misuse	false	MaterialDiversionOrMisuseInd
Members Or Stockholders	Yes (true)	MembersOrStockholdersInd
Election Of Board Members	Yes (true)	ElectionOfBoardMembersInd
Decisions Subject To Approva	Yes (true)	DecisionsSubjectToApprovaInd
Minutes Of Governing Body	Yes (true)	MinutesOfGoverningBodyInd
Minutes Of Committees	Yes (true)	MinutesOfCommitteesInd
Officer Mailing Address	false	OfficerMailingAddressInd
Local Chapters	false	LocalChaptersInd
Form990 Provided To Gvrn Body	Yes (true)	Form990ProvidedToGvrnBodyInd
Conflict Of Interest Policy	Yes (true)	ConflictOfInterestPolicyInd
Annual Disclosure Covered Prsn	Yes (true)	AnnualDisclosureCoveredPrsnInd
Regular Monitoring Enfrc	Yes (true)	RegularMonitoringEnfrcInd
Whistleblower Policy	Yes (true)	WhistleblowerPolicyInd
Document Retention Policy	Yes (true)	DocumentRetentionPolicyInd
Compensation Process CEO	Yes (true)	CompensationProcessCEOInd
Compensation Process Other	Yes (true)	CompensationProcessOtherInd
Investment In Joint Venture	false	InvestmentInJointVentureInd
States Where Copy Of Return Is Fld	WA	StatesWhereCopyOfReturnIsFldCd
Upon Request	Yes (X)	UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Field	Value	IRS element (for citing)
Person	Homer W Lane Jr Executive DirectorC	PersonNm
Phone	2063426508	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	1201 Ninth Avenue	AddressLine1Txt
City	Seattle	CityNm
State Abbreviation	WA	StateAbbreviationCd
ZIP	981012795	ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (29 entries)

TitleTitleTxt	Average Hours Per WeekAverageHoursPerWeekRt	Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd	OfficerOfficerInd	Reportable Comp From OrgReportableCompFromOrgAmt	Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt	Other CompensationOtherCompensationAmt	Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt	Highest Compensated EmployeeHighestCompensatedEmployeeInd
Jane Buckkner MD
Ex Officio, President	040.00	Yes (X)	Yes (X)	$308,899	$0	$25,872
Carla Greenbaum MD
Director	040.00	Yes (X)		$223,629	$0	$30,979
Joyce Lammert MD PhD
Director	001.00	Yes (X)		$0	$829,016	$98,004	050.00
John Corman MD
Director	001.00	Yes (X)		$0	$572,339	$42,318	050.00
Gary Kaplan MD
Director	001.00	Yes (X)		$0	$11,562,939	$154,309	054.00
Tom Cohen
Director	001.00	Yes (X)		$0	$0	$0
Rebecca Campbell
Director	001.00	Yes (X)		$0	$0	$0
Kristi Pangrazio
Director	001.00	Yes (X)		$0	$0	$0	004.00
Margaret Morrow
Director, Secretary	001.00	Yes (X)	Yes (X)	$0	$0	$0
Frank Dvorak PhD
Director, Vice Chair	001.00	Yes (X)	Yes (X)	$0	$0	$0
Patricia Markey
Director	001.00	Yes (X)		$0	$0	$0
Edward Drosdick
Director	001.00	Yes (X)		$0	$0	$0
David Williams
Director, Treasurer	001.00	Yes (X)	Yes (X)	$0	$0	$0
Ditman Johnson
Director	001.00	Yes (X)		$0	$0	$0
W Michael Gallatin PhD
Director	001.00	Yes (X)		$0	$0	$0
Jessica Muffett
Director	001.00	Yes (X)		$0	$0	$0
Carla DewBerry
Director, Chair	001.00	Yes (X)	Yes (X)	$0	$0	$0
Ann Sobil
Director	001.00	Yes (X)		$0	$0	$0
Christopher Wilson MD
Director	001.00	Yes (X)		$0	$0	$0
Nabil Istafanous
Director	001.00	Yes (X)		$0	$0	$0
Ben Reiber
Director	001.00	Yes (X)		$0	$0	$0
Jeffrey Wortley
Director	001.00	Yes (X)		$0	$0	$0
Catherine Zimmerman
Director	001.00	Yes (X)		$0	$0	$0
Homer Lane Jr
Executive Director, CFO	040.00		Yes (X)	$322,159	$0	$32,946
Gerald Nepom MD PhD
Former Ex Officio, Program Director, ITN	032.00			$331,403	$0	$44,844		Yes (X)
William Kwok PhD
Research Member	040.00			$223,404	$0	$27,072		Yes (X)
Steven Ziegler PhD
Director of Academic Affairs	040.00			$214,775	$0	$20,690		Yes (X)
James Lord MD
Research Member	040.00			$205,666	$0	$21,690		Yes (X)
Lynn Rose
Director Scientific Administration	040.00			$187,840	$0	$24,542		Yes (X)

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	$2,017,775	TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org	$12,964,294	TotReportableCompRltdOrgAmt
Total Other Compensation	$523,266	TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K	42	IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed	false	FormerOfcrEmployeesListedInd
Total Comp Greater Than150 K	Yes (true)	TotalCompGreaterThan150KInd
Compensation From Other Srcs	false	CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (3 entries)

Address Line1ContractorAddress/USAddress/AddressLine1Txt	CityContractorAddress/USAddress/CityNm	State AbbreviationContractorAddress/USAddress/StateAbbreviationCd	ZIPContractorAddress/USAddress/ZIPCd	ServicesServicesDesc	CompensationCompensationAmt
Insight Globall LLC
PO Box 198226	Atlanta	GA	30384	Consulting	$750,789
KPMG LLP
1918 Eighth Ave Suite 2900	Seattle	WA	98101	Auditing Consulting	$113,200
Riverbend Design Group LLC
414 Stewart St Suite 215	Seattle	WA	98101	Consulting	$133,913

Field	Value	IRS element (for citing)
Cntrct Rcvd Greater Than100 K	3	CntrctRcvdGreaterThan100KCnt
Related Organizations	$4,000,000	RelatedOrganizationsAmt
Government Grants	$53,520,580	GovernmentGrantsAmt
All Other Contributions	$13,825,915	AllOtherContributionsAmt
Noncash Contributions	$8,038	NoncashContributionsAmt
Total Contributions	$71,346,495	TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (2 entries)

DescDesc	BusinessBusinessCd	Total Revenue ColumnTotalRevenueColumnAmt	Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt
Commercial Studies	621500	$3,604,248	$3,604,248
Collaborative research core services	621500	$4,948,762	$4,948,762

Field	Value	IRS element (for citing)
Total Program Service Revenue	$8,553,010	TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$394,767	TotalRevenueColumnAmt
Exclusion	$394,767	ExclusionAmt

Gross Rents GrossRentsGrp

Field	Value	IRS element (for citing)
Real	$538,260	RealAmt

Less Rental Expenses LessRentalExpensesGrp

Field	Value	IRS element (for citing)
Real	$190,580	RealAmt

Rental Income Or Loss RentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Real	$347,680	RealAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$347,680	TotalRevenueColumnAmt
Exclusion	$347,680	ExclusionAmt

Total Revenue TotalRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$80,641,952	TotalRevenueColumnAmt
Related Or Exempt Func Income	$8,553,010	RelatedOrExemptFuncIncomeAmt
Exclusion	$742,447	ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

Field	Value	IRS element (for citing)
Total	$27,117,157	TotalAmt
Program Services	$27,117,157	ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Foreign Grants ForeignGrantsGrp

Field	Value	IRS element (for citing)
Total	$2,669,093	TotalAmt
Program Services	$2,669,093	ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

Field	Value	IRS element (for citing)
Total	$862,902	TotalAmt
Program Services	$426,726	ProgramServicesAmt
Management And General	$436,176	ManagementAndGeneralAmt

Comp Disqual Persons CompDisqualPersonsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

Field	Value	IRS element (for citing)
Total	$18,971,336	TotalAmt
Program Services	$14,133,576	ProgramServicesAmt
Management And General	$4,837,760	ManagementAndGeneralAmt

Pension Plan Contributions PensionPlanContributionsGrp

Field	Value	IRS element (for citing)
Total	$1,458,076	TotalAmt
Program Services	$1,046,994	ProgramServicesAmt
Management And General	$411,082	ManagementAndGeneralAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

Field	Value	IRS element (for citing)
Total	$3,017,389	TotalAmt
Program Services	$2,166,683	ProgramServicesAmt
Management And General	$850,706	ManagementAndGeneralAmt

Payroll Taxes PayrollTaxesGrp

Field	Value	IRS element (for citing)
Total	$1,354,746	TotalAmt
Program Services	$972,797	ProgramServicesAmt
Management And General	$381,949	ManagementAndGeneralAmt

Fees For Services Management FeesForServicesManagementGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

Field	Value	IRS element (for citing)
Total	$14,055	TotalAmt
Management And General	$14,055	ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

Field	Value	IRS element (for citing)
Total	$93,500	TotalAmt
Management And General	$93,500	ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Field	Value	IRS element (for citing)
Fees For Services Prof Fundraising		FeesForServicesProfFundraising

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Fees For Services Other FeesForServicesOtherGrp

Field	Value	IRS element (for citing)
Total	$3,028,628	TotalAmt
Program Services	$2,319,583	ProgramServicesAmt
Management And General	$709,045	ManagementAndGeneralAmt

Advertising AdvertisingGrp

Field	Value	IRS element (for citing)
Total	$49,177	TotalAmt
Management And General	$49,177	ManagementAndGeneralAmt

Office Expenses OfficeExpensesGrp

Field	Value	IRS element (for citing)
Total	$120,642	TotalAmt
Program Services	$24,353	ProgramServicesAmt
Management And General	$96,289	ManagementAndGeneralAmt

Information Technology InformationTechnologyGrp

Field	Value	IRS element (for citing)
Total	$1,871,865	TotalAmt
Program Services	$891,496	ProgramServicesAmt
Management And General	$980,369	ManagementAndGeneralAmt

Royalties RoyaltiesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Occupancy OccupancyGrp

Field	Value	IRS element (for citing)
Total	$2,683,292	TotalAmt
Program Services	$2,331,358	ProgramServicesAmt
Management And General	$351,934	ManagementAndGeneralAmt

Travel TravelGrp

Field	Value	IRS element (for citing)
Total	$306,847	TotalAmt
Program Services	$258,954	ProgramServicesAmt
Management And General	$47,893	ManagementAndGeneralAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Conferences Meetings ConferencesMeetingsGrp

Field	Value	IRS element (for citing)
Total	$109,201	TotalAmt
Program Services	$91,046	ProgramServicesAmt
Management And General	$18,155	ManagementAndGeneralAmt

Interest InterestGrp

Field	Value	IRS element (for citing)
Total	$822,184	TotalAmt
Program Services	$715,300	ProgramServicesAmt
Management And General	$106,884	ManagementAndGeneralAmt

Payments To Affiliates PaymentsToAffiliatesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Depreciation Depletion DepreciationDepletionGrp

Field	Value	IRS element (for citing)
Total	$3,479,492	TotalAmt
Program Services	$2,775,138	ProgramServicesAmt
Management And General	$704,354	ManagementAndGeneralAmt

Insurance InsuranceGrp

Field	Value	IRS element (for citing)
Total	$43,687	TotalAmt
Management And General	$43,687	ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDesc	TotalTotalAmt	Program ServicesProgramServicesAmt	Management And GeneralManagementAndGeneralAmt
Supplies	$4,063,445	$3,931,380	$132,065
Other Purchased Services	$340,411	$169,889	$170,522
Patient Costs	$1,291,625	$1,291,625
Research Participants Fee	$429,580	$429,580

All Other Expenses AllOtherExpensesGrp

Field	Value	IRS element (for citing)
Total	$759,004	TotalAmt
Program Services	$649,515	ProgramServicesAmt
Management And General	$109,489	ManagementAndGeneralAmt

Total Functional Expenses TotalFunctionalExpensesGrp

Field	Value	IRS element (for citing)
Total	$74,957,334	TotalAmt
Program Services	$64,412,243	ProgramServicesAmt
Management And General	$10,545,091	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

Field	Value	IRS element (for citing)
BOY	$9,334,155	BOYAmt
EOY	$10,525,094	EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

Field	Value	IRS element (for citing)
BOY	$6,095	BOYAmt
EOY	$2,288,001	EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$11,688,324	BOYAmt
EOY	$12,690,871	EOYAmt

Accounts Receivable AccountsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$854,913	BOYAmt
EOY	$1,620,548	EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

Field	Value	IRS element (for citing)
BOY	$454,115	BOYAmt
EOY	$349,640	EOYAmt

Field	Value	IRS element (for citing)
Land Bldg Equip Cost Or Other Bss	$72,050,010	LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec	$42,450,877	LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

Field	Value	IRS element (for citing)
BOY	$30,955,262	BOYAmt
EOY	$29,599,133	EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

Field	Value	IRS element (for citing)
BOY	$9,139,241	BOYAmt
EOY	$5,312,100	EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

Field	Value	IRS element (for citing)
BOY	$22,130,376	BOYAmt
EOY	$28,068,298	EOYAmt

Other Assets Total OtherAssetsTotalGrp

Field	Value	IRS element (for citing)
BOY	$875,680	BOYAmt
EOY	$852,585	EOYAmt

Total Assets TotalAssetsGrp

Field	Value	IRS element (for citing)
BOY	$85,438,161	BOYAmt
EOY	$91,306,270	EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

Field	Value	IRS element (for citing)
BOY	$12,044,459	BOYAmt
EOY	$12,436,607	EOYAmt

Deferred Revenue DeferredRevenueGrp

Field	Value	IRS element (for citing)
BOY	$4,410,224	BOYAmt
EOY	$4,142,907	EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$9,425,000	BOYAmt
EOY	$27,721,490	EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

Field	Value	IRS element (for citing)
BOY	$19,256,490	BOYAmt

Total Liabilities TotalLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$45,136,173	BOYAmt
EOY	$44,301,004	EOYAmt

Field	Value	IRS element (for citing)
Organization Follows SFAS117	Yes (X)	OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$20,378,881	BOYAmt
EOY	$20,816,818	EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$8,690,843	BOYAmt
EOY	$12,225,413	EOYAmt

Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$11,232,264	BOYAmt
EOY	$13,963,035	EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$40,301,988	BOYAmt
EOY	$47,005,266	EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$85,438,161	BOYAmt
EOY	$91,306,270	EOYAmt

Field	Value	IRS element (for citing)
Reconcilation Revenue Expnss	$5,684,618	ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst	$1,018,660	NetUnrlzdGainsLossesInvstAmt
Method Of Accounting Accrual	Yes (X)	MethodOfAccountingAccrualInd
Accountant Compile Or Review	false	AccountantCompileOrReviewInd
FS Audited	Yes (true)	FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

Field	Value	IRS element (for citing)
Separate Basis Fincl Stmt	Yes (X)	SeparateBasisFinclStmtInd

Field	Value	IRS element (for citing)
Audit Committee	Yes (true)	AuditCommitteeInd
Federal Grant Audit Required	Yes (true)	FederalGrantAuditRequiredInd
Federal Grant Audit Performed	Yes (true)	FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Medical Research Organization	Yes (X)	MedicalResearchOrganizationInd

Hospital Name And Address HospitalNameAndAddressGrp

Supported Organization Name SupportedOrganizationName

Field	Value	IRS element (for citing)
Business Name Line1	Virginia Mason Medical Center	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
City	Seattle	CityNm
State Abbreviation	WA	StateAbbreviationCd

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$38,329,362	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$44,973,133	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$54,174,085	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$59,709,893	CurrentTaxYearMinus1YearAmt
Current Tax Year	$71,346,495	CurrentTaxYearAmt
Total	$268,532,968	TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$38,329,362	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$44,973,133	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$54,174,085	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$59,709,893	CurrentTaxYearMinus1YearAmt
Current Tax Year	$71,346,495	CurrentTaxYearAmt
Total	$268,532,968	TotalAmt

Field	Value	IRS element (for citing)
Substantial Contributors Tot	$24,906,893	SubstantialContributorsTotAmt
Public Support Total170	$243,626,075	PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$560,734	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$642,011	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$707,157	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$430,555	CurrentTaxYearMinus1YearAmt
Current Tax Year	$933,027	CurrentTaxYearAmt
Total	$3,273,484	TotalAmt

Other Income170 OtherIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$4,701,834	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$6,122,655	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$6,639,555	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$7,021,290	CurrentTaxYearMinus1YearAmt
Current Tax Year	$8,553,010	CurrentTaxYearAmt
Total	$33,038,344	TotalAmt

Field	Value	IRS element (for citing)
Total Support	$304,844,796	TotalSupportAmt
Public Support CY170	0.79920	PublicSupportCY170Pct
Public Support PY170	0.78320	PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170	Yes (X)	ThirtyThrPctSuprtTestsCY170Ind
Public Support CY509	0.00000	PublicSupportCY509Pct
Investment Income CY	0.00000	InvestmentIncomeCYPct

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

Field	Value	IRS element (for citing)
Contributor	RESTRICTED	ContributorNum

Contributor Business Name ContributorBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	RESTRICTED	BusinessNameLine1

Contributor US Address ContributorUSAddress

Field	Value	IRS element (for citing)
Address Line1	RESTRICTED	AddressLine1
Address Line2	RESTRICTED	AddressLine2
City	RESTRICTED	City
State	RESTRICTED	State
ZIP Code	RESTRICTED	ZIPCode

Field	Value	IRS element (for citing)
Total Contributions	RESTRICTED	TotalContributionsAmt

Schedule C IRS990ScheduleC

Field	Value	IRS element (for citing)
Organization Belongs Afflt Grp	Yes (X)	OrganizationBelongsAffltGrpInd

Total Grassroots Lobbying TotalGrassrootsLobbyingGrp

Field	Value	IRS element (for citing)
Affiliated Group Total	$163,134	AffiliatedGroupTotalAmt

Total Direct Lobbying TotalDirectLobbyingGrp

Field	Value	IRS element (for citing)
Affiliated Group Total	$112,648	AffiliatedGroupTotalAmt

Total Lobbying Expend TotalLobbyingExpendGrp

Field	Value	IRS element (for citing)
Affiliated Group Total	$275,782	AffiliatedGroupTotalAmt

Other Exempt Purpose Expend OtherExemptPurposeExpendGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$74,957,334	FilingOrganizationsTotalAmt
Affiliated Group Total	$1,503,935,718	AffiliatedGroupTotalAmt

Total Exempt Purpose Expend TotalExemptPurposeExpendGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$74,957,334	FilingOrganizationsTotalAmt
Affiliated Group Total	$1,504,211,500	AffiliatedGroupTotalAmt

Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$1,000,000	FilingOrganizationsTotalAmt
Affiliated Group Total	$1,000,000	AffiliatedGroupTotalAmt

Grassroots Nontaxable GrassrootsNontaxableGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$250,000	FilingOrganizationsTotalAmt
Affiliated Group Total	$250,000	AffiliatedGroupTotalAmt

Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp

Field	Value	IRS element (for citing)
Current Year Minus3	$1,000,000	CurrentYearMinus3Amt
Current Year Minus2	$1,000,000	CurrentYearMinus2Amt
Current Year Minus1	$1,000,000	CurrentYearMinus1Amt
Current Year	$1,000,000	CurrentYearAmt
Total	$4,000,000	TotalAmt

Field	Value	IRS element (for citing)
Lobbying Ceiling	$6,000,000	LobbyingCeilingAmt

Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp

Field	Value	IRS element (for citing)
Current Year Minus3	$122,035	CurrentYearMinus3Amt
Current Year Minus2	$138,835	CurrentYearMinus2Amt
Current Year Minus1	$154,766	CurrentYearMinus1Amt
Current Year	$275,782	CurrentYearAmt
Total	$691,418	TotalAmt

Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp

Field	Value	IRS element (for citing)
Current Year Minus3	$250,000	CurrentYearMinus3Amt
Current Year Minus2	$250,000	CurrentYearMinus2Amt
Current Year Minus1	$250,000	CurrentYearMinus1Amt
Current Year	$250,000	CurrentYearAmt
Total	$1,000,000	TotalAmt

Field	Value	IRS element (for citing)
Grassroots Ceiling	$1,500,000	GrassrootsCeilingAmt

Avg Grassroots Lobbying Expend AvgGrassrootsLobbyingExpendGrp

Field	Value	IRS element (for citing)
Current Year Minus3	$114,035	CurrentYearMinus3Amt
Current Year Minus2	$119,335	CurrentYearMinus2Amt
Current Year Minus1	$108,173	CurrentYearMinus1Amt
Current Year	$163,134	CurrentYearAmt
Total	$504,677	TotalAmt

Field	Value	IRS element (for citing)
Volunteers	false	VolunteersInd
Paid Staff Or Management	false	PaidStaffOrManagementInd
Media Advertisements	false	MediaAdvertisementsInd
Mailings Members	false	MailingsMembersInd
Publications Or Broadcast	false	PublicationsOrBroadcastInd
Grants Other Organizations	false	GrantsOtherOrganizationsInd
Direct Contact Legislators	false	DirectContactLegislatorsInd
Rallies Demonstrations	false	RalliesDemonstrationsInd
Other Activities	false	OtherActivitiesInd
Not Described Section501c3	false	NotDescribedSection501c3Ind
Form4720 Filed4912 Tax	false	Form4720Filed4912TaxInd

Supplemental Information Detail SupplementalInformationDetail (5 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
II-A A	Benaroya Research Institute at Virginia Mason, EIN 91-0653422, 1201 Ninth Avenue, Seattle, WA 98101. Non-electing member. 0 Lobbying Expenditures. Excess Lobbying Expenditures 40.
II-A A continued	Virginia Mason Health System, EIN 91-1351110, 1100 Ninth Avenue, Seattle, WA 998101. Non-electing member. 0 Lobbying Expenditures. Excess Lobbying Expenditures 0.
II-A A continued	Virginia Mason Institute, EIN 26-3763656, 1100 Ninth Avenue, Seattle, WA 98101. Non-electing member. 0 Lobbying Expenditures. 0 Excess Lobbying Expenditures.
II-A A continued	Virginia Mason Medical Center, EIN 91-0565539, 1100 Ninth Avenue, Seattle, WA 98101. Electing member. Grassroots Lobbying Expenditures 121,040 Direct Lobbying Expenditures 52,648. Excess Lobbying Expenditures 0. Tax year ending December 31, 1998 was the first year in which Virginia Mason Medical Center made the election under Section 501h. The election was not revoked before the start of the tax year ending December 31, 2016.
II-A A continued	Yakima Valley Memorial Hospital Association, EIN 91-0567263, 2811 Tieton Drive, Yakima, WA 98902. Non-electing member. Grassroots Lobbying Expenditures 42,094 Direct Lobbying Expenditures 60,000. Excess Lobbying Expenditures 0.

Schedule D IRS990ScheduleD

Field	Value	IRS element (for citing)
Incl Escrow Custodial Acct Liab	false	InclEscrowCustodialAcctLiabInd
Endowments Held Unrelated Org	false	EndowmentsHeldUnrelatedOrgInd
Endowments Held Related Org	Yes (true)	EndowmentsHeldRelatedOrgInd
Related Org List Sch R	Yes (true)	RelatedOrgListSchRInd

Land LandGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$756,906	OtherCostOrOtherBasisAmt
Book Value	$756,906	BookValueAmt

Buildings BuildingsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$49,143,699	OtherCostOrOtherBasisAmt
Depreciation	$24,861,836	DepreciationAmt
Book Value	$24,281,863	BookValueAmt

Leasehold Improvements LeaseholdImprovementsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$196,862	OtherCostOrOtherBasisAmt
Depreciation	$196,862	DepreciationAmt

Equipment EquipmentGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$21,697,346	OtherCostOrOtherBasisAmt
Depreciation	$17,392,179	DepreciationAmt
Book Value	$4,305,167	BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$255,197	OtherCostOrOtherBasisAmt
Book Value	$255,197	BookValueAmt

Field	Value	IRS element (for citing)
Total Book Value Land Buildings	$29,599,133	TotalBookValueLandBuildingsAmt

Other Securities OtherSecuritiesGrp (3 entries)

DescDesc	Book ValueBookValueAmt	Method ValuationMethodValuationCd
Financial derivatives and other financial products
Closely-held equity interests
Interest in Net Assets of Virginia Mason Health System	$28,068,298	F

Field	Value	IRS element (for citing)
Total Book Value Securities	$28,068,298	TotalBookValueSecuritiesAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

Field	Value	IRS element (for citing)
Desc	Federal income taxes	Desc

Field	Value	IRS element (for citing)
Total Rev Etc Audited Fincl Stmt	$81,660,612	TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst	$1,018,660	NetUnrealizedGainsInvstAmt
Revenue Not Reported	$1,018,660	RevenueNotReportedAmt
Revenue Subtotal	$80,641,952	RevenueSubtotalAmt
Total Revenue Per Form990	$80,641,952	TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt	$74,957,334	TotExpnsEtcAuditedFinclStmtAmt
Expenses Subtotal	$74,957,334	ExpensesSubtotalAmt
Total Expenses Per Form990	$74,957,334	TotalExpensesPerForm990Amt

Schedule F IRS990ScheduleF

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (true)	GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (3 entries)

RegionRegionTxt	Type Of Activities ConductedTypeOfActivitiesConductedTxt	Specific Services ProvidedSpecificServicesProvidedTxt	Region Total ExpendituresRegionTotalExpendituresAmt
East Asia and the Pacific	Conferences	Medical Research	$5,066
Europe Including Iceland and Greenland	Conferences	Medical Research	$27,913
South America	Conferences	Medical Research	$283

Field	Value	IRS element (for citing)
Subtotal Spent	$33,262	SubtotalSpentAmt
Total Spent	$33,262	TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (13 entries)

RegionRegionTxt	Purpose Of GrantPurposeOfGrantTxt	Cash GrantCashGrantAmt	Manner Of Cash DisbursementMannerOfCashDisbursementTxt
Europe Including Iceland and Greenland	Medical Research	$48,125	Wire Transfer
Europe Including Iceland and Greenland	Medical Research	$547,049	Wire Transfer
Europe Including Iceland and Greenland	Medical Research	$853,701	Wire Transfer
Europe Including Iceland and Greenland	Medical Research	$60,534	Wire Transfer
Europe Including Iceland and Greenland	Medical Research	$47,312	Wire Transfer
Europe Including Iceland and Greenland	Medical Research	$11,744	Wire Transfer
Europe Including Iceland and Greenland	Medical Research	$191,203	Wire Transfer
North America	Medical Research	$29,292	Wire Transfer
North America	Medical Research	$488,253	Wire Transfer
North America	Medical Research	$138,963	Wire Transfer
North America	Medical Research	$79,571	Wire Transfer
North America	Medical Research	$99,896	Wire Transfer
North America	Medical Research	$73,450	Wire Transfer

Field	Value	IRS element (for citing)
Total Other Org	13	TotalOtherOrgCnt
Transfer To Foreign Corp	false	TransferToForeignCorpInd
Interest In Foreign Trust	false	InterestInForeignTrustInd
Foreign Corp Ownership	false	ForeignCorpOwnershipInd
Passive Foreign Investmest Co	false	PassiveForeignInvestmestCoInd
Foreign Partnership	false	ForeignPartnershipInd
Boycott Countries	false	BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
Part I Line 2	Subrecipient Monitoring Policy - medical research sub awards - BRI has formal policies and procedures to assure full compliance with applicable policies and laws governing federal grants. The Subrecipient Monitoring Policy provides assurance that subrecipients comply with federal grant regulations. This policy sets the criteria to establish eligibility of subrecipients to provide annual audited financial reports and the annual OMB single audit report that identify compliance with federal laws and regulations. The reports are analyzed with emphasis on auditors assessment of subrecipient internal controls and a standardized risk assessment is presented to management on each subrecipient. A Management Letter is issued to each subrecipient showing any findings on their OMB single audit report, and measurements are set for increased monitoring when an elevated level of risk is established. Management has communicated with an educated administrative staff regarding implementation of this policy. The Director of Grants and Contracts is responsible for monitoring subrecipient adherence to financial regulations. The principal investigator is responsible for overseeing the satisfactory performance of the sub-award to ensure that goals are achieved. If there are unusual or unforeseen items, these will be investigated.
Part I Line 3f	The expenditures were actual expenses incurred in the region based on individual expense reports and tracking of expenditures by grant or department on the accrual basis of accounting.
Part II Line 1	The expenditures were expenses incurred in the region based on award goals on the accrual basis of accounting.

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (true)	GrantRecordsMaintainedInd

Recipient Table RecipientTable (70 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	Recipient EINRecipientEIN	IRC SectionIRCSectionDesc	Cash GrantCashGrantAmt	Purpose Of GrantPurposeOfGrantTxt
Ann&Robert H Lurie Children's Hospital of Chicago
225 East Chicago Ave No 205	Chicago	IL	606112991	362170833	501c3	$24,908	Medical Research
Arizona State University
Office for Research and Sponsored P	Tempe	AZ	852876011	860196696	Arizona	$36,721	Medical Research
Arkansas Children's Hospital Research Institute
One Childrens Way Financial Service	Little Rock	AR	722023591	710694931	501c3	$70,483	Medical Research
Asthma Inc
9725 3rd Ave NE Suite 500	Seattle	WA	98115	237219813	501c3	$442,875	Medical Research
Baylor Research Institute
3301 Live Oak Suite 501	Dallas	TX	75204	751921898	501c3	$45,742	Medical Research
Baylor College of Medicine
7200 Cambridge St 9th Floor	Houston	TX	77030	741613878	501c3	$13,547	Medical Research
Brigham And Women's Hospital
Bank of America NA POBox 3887	Boston	MA	022413887	042312909	501c3	$249,272	Medical Research
Case Western Reserve University
10900 Euclid Avenue Nord Hall Suite	Cleveland	OH	441067037	341018992	501c3	$33,617	Medical Research
Columbia University Trustees of
PO Box 29789 General Post Office	New York	NY	100879789	135598093	501c3	$378,068	Medical Research
Dana-Farber Cancer Institute Inc
450 Brookline Ave 431C	Boston	MA	02215	042263040	501c3	$223,659	Medical Research
Denver Nephrologists PC
130 Rampart Way Suite 300B	Denver	CO	80230	840591433		$15,602	Medical Research
Dermatology Research Assoc Inc
301 Carriage Place	Manhatten Beach	CA	90266	273947370		$96,549	Medical Research
Duke University
PO Box 602651 Accounts Receivable L	Charlotte	NC	282602651	560532129	501c3	$441,237	Medical Research
Emory University
1599 Clifton Road NE 4th floor	Atlanta	GA	30322	580566256	501c3	$337,707	Medical Research
Feinstein Institute for Medical Research
350 Community Drive	Manhasset	NY	11030	112673595	501c3	$63,424	Medical Research
Fred Hutchinson Cancer Research Center
1100 Fairview Ave N J6-330 PO Box 1	Seattle	WA	981091024	237156071	501c3	$32,609	Medical Research
Hospital for Special Surgery
535 East 70th Street	New York	NY	10021	131624135	501c3	$29,423	Medical Research
Icahn School of Medicine at Mount Sinai
One Gustave L Levy Place Box 3500 O	New York	NY	100296574	136171197	501c3	$228,337	Medical Research
Indiana University
400 E 7th St Poplars Room 501	Bloomington	IN	47405	356001673	501c3	$100,375	Medical Research
Johns Hopkins University
Central Lockbox c/o B of A 12529 Co	Chicago	IL	60693	520595110	501c3	$1,637,275	Medical Research
Jonathan Corren MD Inc
10780 Santa Monica Blvd 280 Allergy	Los Angeles	CA	90025	462346264		$334,001	Medical Research
Joslin Diabetes Center
One Joslin Place	Boston	MA	022155306	042203836	501c3	$78,804	Medical Research
Lahey Clinic Inc
41 Mall Rd Attn Office of Research	Burlington	MA	01805	042704683	501c3	$26,418	Medical Research
La Jolla Institute for Allergy & Immunology
9420 Athena Circle	La Jolia	CA	92037	330328688	501c3	$77,979	Medical Research
Massachusetts General Hospital
55 Fruit Street Research Management	Boston	MA	02114	042697983	501c3	$5,435,581	Medical Research
Medical College of Wisconsin
Accounts Receivable PO Box 26509	Milwaukee	WI	532260509	390806261	501c3	$69,333	Medical Research
Medical University of South Carolina
19 Hagood Avenue Ste 604 MSC 808	Charleston	SC	29425	576000722	South Carolina	$59,703	Medical Research
National Jewish Health
1400 Jackson Street M213	Denver	CO	80206	742044647	501c3	$141,079	Medical Research
New York University-School of Medicine
PO Box 415026 Bank of America	Boston	MA	022415026	135562308	501c3	$259,762	Medical Research
Northwestern University
750 N Lake Shore Drive	Chicago	IL	60611	362167817	501c3	$694,031	Medical Research
Ohio State University
Office of Sponsored Programs 1960 K	Columbus	OH	43210	316025986	501c3	$29,096	Medical Research
Oklahoma Medical Research Foundation
825 NE 13th Street	Oklahoma City	OK	73104	730580274	501c3	$159,942	Medical Research
Polyclinic
Madison Center 904 7th Ave 6th Floo	Seattle	WA	98104	910369070		$19,760	Medical Research
Rockefeller University
1230 York Ave Financial Post Award	New York	NY	100656307	131624158	501c3	$181,417	Medical Research
Rogosin Institute
505 East 70th Street 2nd Floor	New York	NY	100214872	133184198	501c3	$17,639	Medical Research
Rutgers the State University of New Jersey
Office of Research and Sponsored Pr	New Brunswick	NJ	089018559	226001086	501c3	$491,506	Medical Research
Sanford Research
2301 E 60th St N Attn Clinical Rese	Sioux Falls	SD	57104	460450378	501c3	$76,491	Medical Research
Seattle Childrens Hospital
PO Box 24728	Seattle	WA	981240728	910564748	501c3	$137,110	Medical Research
Stanford University
PO Box 44253	San Francisco	CA	941444253	941156365	501c3	$833,372	Medical Research
State University of Iowa
105 Jessup Hall	Iowa City	IA	52242	426004813	Iowa	$10,892	Medical Research
St Jude Children's Research Hospital Inc
PO Box 1000 Dept 949	Memphis	TN	381480949	620646012	501c3	$223,994	Medical Research
Swedish Health Services - Swedish Physicians LLC
Swedish MC - Research Center PO Box	Seattle	WA	981249845	911942315		$15,100	Medical Research
Tulane University
1430 Tulane Ave Dermatology 8036 At	New Orleans	LA	70112	720423889	501c3	$82,816	Medical Research
University of Miami
PO Box 025405 Location 3	Miami	FL	331025405	590624458	501c3	$7,724	Medical Research
University of Washington
Box 94224	Seattle	WA	981246524	916001537	501c3	$582,216	Medical Research
University of Michigan
Box 223131	Pittsburgh	PA	152512131	386006309	501c3	$90,525	Medical Research
University of Utah
Utah Diabetes Center 615 Arapeen D	Salt Lake City	UT	84108	876000525	501c3	$64,322	Medical Research
Univ of Minnesota Regents
450 McNamara Alumni Center 200 Oak	Minneapolis	MN	554552070	416007513	Minnesota	$61,814	Medical Research
Univ of Texas SW Med Ctr
Grants Management PO Box 841753	Dallas	TX	752841753	756002868	Texas	$66,724	Medical Research
University of Colorado-Denver
PO Box 910238	Denver	CO	802910238	846000555	501c3	$1,947,529	Medical Research
University of Chicago
Section Of Endocrinology 5841 S Mar	Chicago	IL	60637	362177139	501c3	$267,199	Medical Research
University of California The Regents of
Accounting Office CGA Box 0897	San Francisco	CA	941430897	946002123	501c3	$13,586	Medical Research
University of Pittsburgh
200 Lothrop St E1140 Biomedical Sci	Pittsburgh	PA	15213	250965591	501c3	$424,490	Medical Research
University of Oklahoma
Dept of ORL PO Box 26901 WP-1290	Oklahoma City	OK	731269818	731377584	501c3	$109,130	Medical Research
University of Pennsylvania
PO Box 785541	Philadelphia	PA	171785541	231352685	501c3	$174,137	Medical Research
University of Florida Board of Trustees
PO Box 113001	Gainesville	FL	32611	596002052	501c3	$33,041	Medical Research
University of Nebraska Medical Center
985045 Nebraska Medical Center	Omaha	NE	681985045	470049123	501c3	$36,607	Medical Research
University of Maryland Baltimore
Sponsored Projects Acctng 220 Arch	Baltimore	MD	212011508	526002033	Maryland	$18,713	Medical Research
University of North Carolina at Chapel Hill
PO Box 402420 Bank of America Lockb	Atlanta	GA	303842420	566001393	501c3	$694,818	Medical Research
University of Texas MD Anderson Cancer Ctr
PO Box 4390 Grants Contract Acctng	Houston	TX	772104390	746001118	501c3	$11,923	Medical Research
University of Wisconsin Madison Board of Regents
600 Highland Ave F8/138 CSC	Madison	WI	53792	396006492	501c3	$389,888	Medical Research
University of California San Francisco
Controllers Office Contract Grants	San Francisco	CA	941430897	946036493	501c3	$7,304,374	Medical Research
University of Alabama at Birmingham
1720 2nd Ave South AB 990	Birmingham	AL	35294	636005396	Alabama	$24,499	Medical Research
University of North Carolina at Greensboro
2511 MHRA Building PO Box 26170	Greensboro	NC	274026170	566001468	501c3	$58,271	Medical Research
University of California Los Angeles
11000 Kinross Ave Ste 211	Los Angeles	CA	90095	956006143	501c3	$93,170	Medical Research
Vital Prospects Clinical Research Institute PC
7307 S Yale Ave Suite 200	Tulsa	OK	74136	261814411		$24,194	Medical Research
Wake Forest University Health Sciences
Medical Center Boulevard	WinstonSalem	NC	27157	223849199	501c3	$35,009	Medical Research
Western Michigan University School of Medicine
PO Box 50391	Kalamazoo	MI	490050391	454135256	501c3	$7,758	Medical Research
Winthrop University Hospital
Dept of Finance 700 Hicksville Road	Bethpage	NY	11714	111633486	501c3	$33,147	Medical Research
Yale University
Grant and Contract Financial Admini	New Haven	CT	065081873	080648973	501c3	$583,741	Medical Research

Field	Value	IRS element (for citing)
Total501c3 Org	64	Total501c3OrgCnt
Total Other Org	6	TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDesc

ExplanationExplanationTxt

Part I Line 2

Subrecipient Monitoring Policy - medical research sub awards - BRI has formal policies and procedures to assure full compliance with applicable policies and laws governing federal grants. The Subrecipient Monitoring Policy provides assurance that subrecipients comply with federal grant regulations. This policy sets the criteria to establish eligibility of subrecipients to provide annual audited financial reports and the annual OMB single audit report that identify compliance with federal laws and regulations. The reports are analyzed with emphasis on auditors assessment of subrecipient internal controls and a standardized risk assessment is presented to management on each subrecipient. A Management Letter is issued to each subrecipient showing any findings on their OMB single audit report, and measurements are set for increased monitoring when an elevated level of risk is established. Management has communciated with an educated administrative staff regarding implementation of this policy.

Part I Line 2 continued

The Director of Grants and Contracts is responsible for monitoring subrecipient adherence to financial regulations. The principal investigator is responsible for overseeing the satisfactory performance of the sub-award to ensure that goals are achieved. If there are unusual or unforeseen items, these will be investigated.

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
First Class Or Charter Travel	Yes (X)	FirstClassOrCharterTravelInd
Written Policy Ref T And E Expnss	Yes (true)	WrittenPolicyRefTAndEExpnssInd
Substantiation Required	Yes (true)	SubstantiationRequiredInd
Severance Payment	false	SeverancePaymentInd
Supplemental Nonqual Rtr Plan	Yes (true)	SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm	false	EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org	false	CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs	false	CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org	false	CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs	false	CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments	false	AnyNonFixedPaymentsInd
Initial Contract Exception	false	InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (11 entries)

TitleTitleTxt	Base Compensation Filing OrgBaseCompensationFilingOrgAmt	Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt	Total Compensation Filing OrgTotalCompensationFilingOrgAmt	Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt	Bonus Related OrganizationsBonusRelatedOrganizationsAmt	Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt	Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt	Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt	Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt	Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt	Bonus Filing OrganizationBonusFilingOrganizationAmount
Jane Buckkner MD
Ex Officio, President	$308,999	$24,000	$1,872	$334,871
Carla Greenbaum MD
Director	$223,629	$24,000	$6,979	$254,608
Joyce Lammert MD PhD
Director					$453,400	$120,892	$254,724	$86,450	$11,554	$927,020	$126,000
John Corman MD
Director					$553,925		$18,414	$19,643	$22,675	$614,657
Gary Kaplan MD
Director					$1,066,494	$441,298	$10,055,147	$111,126	$43,183	$11,717,248	$8,352,547
Homer Lane Jr
Executive Director, CFO	$254,665	$24,000	$8,946	$355,105								$67,494
Gerald Nepom MD PhD
Former Ex Officio, Program Director, ITN	$228,626	$42,000	$2,844	$376,247								$102,777
William Kwok PhD
Research Member	$222,839	$24,000	$3,072	$250,476								$565
Steven Ziegler PhD
Director of Academic Affairs	$214,211	$16,334	$4,356	$235,466								$565
James Lord MD
Research Member	$205,666	$17,634	$4,056	$227,356
Lynn Rose
Director Scientific Administration	$187,275	$19,148	$5,394	$212,382								$565

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
Part I Line 3	Benaroya Research Institute at Virginia Mason BRI delegates to Virginia Mason Health Systems its parent and sole member Board Compensation and Benefits Committee, a committee composed of independent Health System Board members to whom the BRI Board has delegated the authority to approve all compensation and benefits for the executive leaders of BRI. To ensure that such benefit plans are market competitive and reasonable, the Committee receives support and advice, including appropriate market comparability data from an independent compensation consultant with expertise in the health care industry and access to relevant market data. See Schedule O for additional disclosure.
Part I Line 4b	The Virginia Mason Medical Center has a Supplemental Executive Retirement Plan SERP in which certain BRI Executives particpate. The SERP is a 457 f nonqualified deferred compensation plan pursuant to which plan benefits are subject to a substantial risk of forfeiture, entered into in connection with certain senior executives joining the Medical Center. The plan was approved by the Boards Compensation and Benefits Committee, a committee composed of independent board members to whom the Board delegates the authority to approve compensation and benefits to the Medical Centers most senior executives. The Committee receives advice from an independent compensation consultant to ensure that compensation and benefits, including the SERP, are market competitive and reasonable. Supplemental Executive Retirement Plans such as this are customary for senior executives in the health care industry.
Part I Line 4b	Gary Kaplan, M.D. received a payment of 10,031,813 from a Supplemental Executive Retirement Plan. Joyce Lammert, M.D. received a 234,438 payout from a Supplemental Executive Retirement Plan. Gary Kaplan M.D. accrued benefits in a Supplemental Executive Retirement Plan of 96,280. Joyce Lammert, M.D. accrued benefits in a Supplemental Executive Retirement Plan of 63,000.

Schedule K IRS990ScheduleK

Tax Exempt Bonds Issues TaxExemptBondsIssuesGrp (2 entries)

Bond ReferenceBondReferenceCd	Bond Issuer EINBondIssuerEIN	Bond IssuedBondIssuedDt	Issue PriceIssuePriceAmt	PurposePurposeDesc	DefeasedDefeasedInd	On Behalf Of IssuerOnBehalfOfIssuerInd	Pool FinancingPoolFinancingInd
WA Econ Devel Fin Auth-2012 Series B
A	911493002	2012-06-01	$10,390,000	See Part VI	false	Yes (true)	false
WA Econ Devel Fin Auth-Series 2016
B	911493002	2016-06-01	$18,631,490	See Part VI	false	Yes (true)	false

Tax Exempt Bonds Proceeds TaxExemptBondsProceedsGrp (2 entries)

Bond ReferenceBondReferenceCd	RetiredRetiredAmt	Total ProceedsTotalProceedsAmt	Capital ExpendituresCapitalExpendituresAmt	Other Spent ProceedsOtherSpentProceedsAmt	Substantial CompletionSubstantialCompletionYr	Current RefundingCurrentRefundingInd	Advance RefundingAdvanceRefundingInd	Final Allocation MadeFinalAllocationMadeInd	Adequate Books And Rec MaintAdequateBooksAndRecMaintInd
A	$1,300,000	$10,390,348	$2,550,348	$7,840,000	2013	Yes (true)	false	Yes (true)	Yes (true)
B		$18,631,490		$18,631,490		Yes (true)	false	Yes (true)	Yes (true)

Tax Exempt Bonds Private Bus Use TaxExemptBondsPrivateBusUseGrp (2 entries)

Bond ReferenceBondReferenceCd	Owning Bond Financed PropertyOwningBondFinancedPropertyInd	Any Lease ArrangementsAnyLeaseArrangementsInd	Mgmt Contract Bond Fincd PropMgmtContractBondFincdPropInd	Any Research AgreementsAnyResearchAgreementsInd	Engage Bond Counsel ResearchEngageBondCounselResearchInd	Private Bus Use By OthersPrivateBusUseByOthersPct	Total Private Business UseTotalPrivateBusinessUsePct	Bond Iss Meet Prvt Sec Pymt TestBondIssMeetPrvtSecPymtTestInd	Change In Use Bond Financed PropChangeInUseBondFinancedPropInd	Procs Nonqualified Bond RemdtdProcsNonqualifiedBondRemdtdInd
A	false	Yes (true)	false	Yes (true)	Yes (true)	0.01180	0.01180	false	false	Yes (true)
B	false	Yes (true)	false	Yes (true)	Yes (true)	0.01180	0.01180	false	false

Tax Exempt Bonds Arbitrage TaxExemptBondsArbitrageGrp (2 entries)

Bond ReferenceBondReferenceCd	Form8038 T FiledForm8038TFiledInd	Rebate Not Due YetRebateNotDueYetInd	Variable Rate IssueVariableRateIssueInd	Hedge Identified In Bks And RecHedgeIdentifiedInBksAndRecInd	Gross Proceeds Invested In GICGrossProceedsInvestedInGICInd	Gross Proceeds InvestedGrossProceedsInvestedInd	Written Proc To Monitor ReqsWrittenProcToMonitorReqsInd
A	false	Yes (true)	false	false	false	false	Yes (true)
B	false	Yes (true)	false	false	false	false	Yes (true)

Procedures Corrective Action ProceduresCorrectiveActionGrp (2 entries)

Bond ReferenceBondReferenceCd	Procedures Corrective ActionProceduresCorrectiveActionInd
A	Yes (true)
B	Yes (true)

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
Part I Line A Column F	Purposes to currently refund WEDFA Series 2006C bonds issued 11/15/2006, and to fund research facility improvements.
Part I Line B Column F	Purposes to currently refund WEDFA Series 2012A taxable bonds issued 06/01/2012. No tax-exempt private activity bonds are being refunded.
Part II Line 3 Column A	Difference between Part I, column e and Part II, Line 3 is investment earnings.

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (12 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
Form 990, Part III, Line 1	Benaroya Research Institute at Virginia Mason BRI is a world-renowned medical research institute whose work has resulted in major advances in our understanding of autoimmune and immune-mediated diseases. BRI is affiliated with the Virginia Mason Health System, which provides governance oversight and development support through the Virginia Mason Foundation. In 2016, BRI researchers generated 90 scientific publications that were published in prestigious research journals and delivered 94 presentations at domestic and international research conferences. One in 15 Americans suffers from an autoimmune disease and many suffer from more than one. These diseases include type 1 diabetes, multiple sclerosis, Crohns disease and rheumatoid arthritis to name a few. Even more Americans, one out of every four, suffer from other immune-mediated diseases, allergy and asthma. Because these diseases are connected by common destructive pathways, research on one or two immune system diseases has far reaching implications for the whole spectrum of immune-mediated disease. As a world leader in scientific innovation, BRIs discoveries are having significant impact on people living with these diseases today-by improving the ability to predict disease risk, prevent onset of disease, decrease disease progression and make treatments safer and better.
Form 990, Part III, Line 4	One of the unique qualities of BRI is the close integration of three types of medical research - laboratory research, translational research and clinical research - to improve peoples lives. Our scientists can address both the basic science issues and clinical applications, which is the best way to design studies with the highest potential for success. For BRI, discovery starts in the laboratory. 2016 advancements in translational, immunology, clinical research and other areas are highlighted below.
Form 990, Part III, Line 4a	Funding for the Immune Tolerance Network ITN was awarded to BRIs Dr. Jerry Nepom in 2014 from the National Institute of Allergy and Infectious Disease NIAID of the National Institutes of Health NIH. The 7-year award, totaling 27 million annually supports the ITN, a research consortium established in 1999 with a primary focus on the development of new tolerogenic approaches for the treatment and prevention of disease in three clinical areas asthma and allergic diseases autoimmune diseases and immune-mediated rejection of transplanted solid organs, tissues and cells. As the Prime recipient of this grant, BRI is responsible for the overall management of the grant from NIAID including oversight of all aspects of the Networks infrastructure. The major activities in 2016 were diverse, but continued to center on preserving the ITNs cohesive project focused environment and its framework which has proven so successful in the management of a large cooperative agreement grant. Key outcomes in 2016 include the following 1 Cross Network Integration A top priority in this reporting period was to continue the successful ITN infrastructure which is spread across three main operational sites. This required careful planning and collaboration as the ITNs major centers of operations are geographically diverse, located in Seattle, San Francisco and Bethesda. Few changes were made to the existing network integration as the current model continues to successfully support the overall ITN program. Establishing new relationships and vital connections within the research community continued to be an ITN goal. 2 Operations and Clinical Trial Support The ITN program team at BRI issued 161 subawards in 2016 in support of 20 active ITN clinical trials and numerous supporting ITN mechanistic trials. 3 Supplemental Funding / Partnerships ITN central administration continued to focus on identifying additional opportunities for supplemental funding and/or funding partnerships. a Supplemental Funding Opportunities The ITN Program Team at BRI submitted one supplemental funding request in 2016. This request was awarded, bringing in an additional 4.9M in funding to the ITN BRI. b Partnerships The ITN continued its relationship with pharmaceutical partners for partial funding for two ITN studies with NIAID as the clinical sponsor. 4 Publication Activity In 2016, 25 ITN publications were published in prestigious research journals and were presented at domestic and international research conferences. These publications represented ITN research in all therapeutic focus areas Type 1 Diabetes, Transplant, Autoimmune disease and Allergy and Asthma.
Form 990, Part III, Line 4b	Translational research is a scientific approach that allows research observations made at the bench to be quickly tested in patients, at the bedside and brought back to the bench again in an expedient and systematic way. This research is translating new methods that improve our ability to predict disease risk, prevent onset of disease, decrease disease progression and make treatments safer and better. The research emphasis of the BRI Translational Research Program is the area of autoimmune and immune-mediated diseases. BRI scientists and physician collaborators work together to study blood and serum samples along with medical and demographic data collected from people with autoimmune and immune-mediated diseases. These include multiple sclerosis, type 1 diabetes, lupus, rheumatoid arthritis, inflammatory bowel disease, allergy and asthma. BRI maintains an extensive biorepository with samples dating back to 2000, including seven disease categories and a biorepository of healthy people for comparison purposes. Advancements in 2016 include the following 1 Connecting Cancer to Immunotherapy Research - In addition to autoimmune disease research, BRI scientists are actively investigating new cancer immunotherapies as a means of understanding the underlying causes of autoimmunity. Many cancer patients treated with specific immune-therapeutics have been observed to develop autoimmune syndromes, many of them long-lasting. This research is being conducted in partnership with Virginia Mason Medical Center. A major component of this research is the development of a robust tissue repository that includes tumor samples, blood samples and demographic data from patients with a variety of cancer types including pancreatic, colorectal, lung and breast tumors. 2 Translational Research Symposium - The annual Clinical and Translational Research Symposium, sponsored by the Wilske Center for Translational Research, took place at Virginia Mason Medical Center. The event connected researchers and clinicians by highlighting the range of clinical and translational research being conducted at BRI. Of the more than 60 research abstracts submitted, the Wilske committee selected the top eight abstracts for oral presentation. 3 Gene Editing - BRI and Seattle Childrens Research Institute SCRI are collaborating on a preclinical study pioneering the use of gene editing techniques in efforts to control type 1 diabetes. To attack this complex problem, BRI is combining its regulatory T cell expertise with SCRIs gene editing expertise. 4 Studying Rheumatoid Arthritis RA - BRI continues its research into studying how RA starts and progresses, and have found the disease begins years before clinical signs and symptoms are apparent. The goal is to understand the disease so it can be prevented before it even starts. Researach into monitoring disease activity during therapy and predicting patient drug responses are also underway. 5 Understanding Antigen-Specific T Cells - Using single-cell RNA sequencing, researchers are investigating T cell receptors and genes expressed by antigen-specific T cells. This could pave the way to monitor, treat and prevent diseases like type 1 diabetes.
Form 990, Part III, Line 4c	BRI is dedicated to seeking ways to eliminate type 1 diabetes, while at the same time looking for therapies to prevent, reverse and intervene in the disease at all stages. BRI is an international leader in type 1 diabetes research and has investigated it for more than 30 years, starting with identification of a genetic marker for the disease. BRI continues to lead the Type 1 Diabetes TrialNet, a National Institutes of Health-funded clinical trial network for type 1 diabetes prevention and early treatment. BRI also serves as the TrialNet Hub that includes 23 clinical centers working in cooperation with more than 200 screening and clinical research sites throughout the U.S. and six other countries.
Form 990, Part III, Line 4d	1 Clinical Research Program Benaroya Research Institute oversees all clinical research at Virginia Mason Medical Center which uniquely combines the expertise of a world-renowned medical research institute with the remarkable care of a healthcare quality leader. The BRI Clinical Research Program supports Virginia Mason Medical Center clinical investigators in studies across a wide variety of diseases and conditions, such as cardiology and cancer. Each year the Clinical Research Program staff enrolls more than 1500 study participants in Virginia Mason Medical Center trials. This program involves approximately 170 research investigators, oversees 440 active studies and has 135 studies currently open to enrollment. 2 Immunology Research Program a Leadership of Asthma and Allergic Diseases Cooperative Research Center - BRI received a five-year grant from the National Institute of Allergy and Infectious Diseases to study the immune systems responses to allergens in the lungs. Investigators at BRI, University of Washington Medicine and Seattle Childrens Research Institute will collaborate to gain insights into the lung epithelium. Dr. Steve Ziegler will lead the project along with eight other principal investigators from the other two institutions. b Understanding cell communication in the gut by studying special rare cells which organize communications, to understand how they can cause inflammatory bowel disease. c Developing new experimental models to understand how the oral drug fingolimod works in multiple sclerosis at a molecular level and how it is modulating different cells of the immune system. Does the drug work differently in different people and on different immune cells Eventually this information will help clinicians to match the right drug to the right person at the right time. d Lung in a Dish - In collaboration with Seattle Childrens Research Institute SCRI scientists at BRI have created a modeling system of the human lung in a laboratory dish to study asthma, allergies and respiratory diseases in children. They hope to understand mechanisms that drive childhood asthma, which will lead to novel therapies for this common condition. e Critical Discovery in Peanut Allergy - Scientists at BRI recently discovered a critical pathway in peanut allergy that may extend to other food allergies. The pathway is triggered by Interleukin 33 IL-33, a protein that helps drive the immune response that promotes allergic reactions to a substance, such as peanuts, that in most people is generally harmless. f Discovering a Biomarker to Fight Allergies - Scientists are pioneering new allergy research using a rare type of immune cell, called TH2A, identified at BRI that is associated with all allergic diseases. g T Cell Response to Different Challenge - Researchers are working to pinpoint how T cells tailor their response to different challenges, since its becoming clear that T cells play a role not just in fighting infections, but in things as diverse as Alzheimers disease, obesity, and wound repair. h Studying the P13-Kinase Enzyme-Scientists are now taking a closer look at how P13-kinase pathways activate T cells and influence how they develop as well as what happens when this process malfunctions. The P13-kinase work is part of their effort to generate insights that could eventually lead to improved therapies for both fighting cancer and stopping autoimmune diseases. 3 Matrix Biology Research Program a The Pathogenic Nature of the Extracellular Matrix in Rheumatoid Arthritis - Scientists are working to discover whether the extracellular matrix and two of its components, hyaluronan and versican, are remodeled differently in the joint synovium of rheumatoid arthritis patients compared to that of osteoarthritis patients and whether these differences lead to a more pervasive and heightened form of inflammation in RA as compared to OA synovium. b Mechanisms of Inflammation in Viral-triggered Asthma - Working with immunologists and physician-scientists at Seattle Childrens Research Institute, matrix biologists are investigating mechnisms responsible for airway extracellular matrix dysregulation in asthma, and the resulting increased adhesion and activation of leukocytes.
Form 990, Part VI, Section A, Line 1a	The governing body delegates to an Executive Committee comprised of four officers of the Board and the Chairs of each standing Board Committee, the authority of the Board of Directors in the management of the corporation as may be deemed by the Executive Committee to be appropriate, to be exercised in time periods between regularly scheduled meetings of the Board of Directors provided that the Executive Committee has the authority to act only in time sensitive or emergency situations. The Director and the Executive Director of the corporation serve as ex officio members of the Executive Committee without voting rights. The Executive Committee does not have the authority to amend, alter or repeal the bylaws elect, appoint or remove any member of such Executive Committee or any director or officer of the corporation amend the articles of incorporation adopt a plan of merger or adopt a plan of consolidation with another corporation authorize the sale, lease or exchange of all or substantially all the property and assets of the corporation not in the ordinary course of business authorize the voluntary dissolution of the corporation or revoke proceedings therefore adopt a plan for the distribution of the assets of the corporation or amend, alter or repeal any resolution of the Board which by its terms provides that it shall not be amended, altered or repealed by such Executive Committee. The Executive Committee also serves as the planning committee for the Board of Directors and oversees any compliance issues raised by the Board of Directors.
Form 990, Part VI, Section A, Line 6, 7	Virginia Mason Health System VMHS is the sole corporate member of Benaroya Research Institute at Virginia Mason BRI. VMHS as the sole voting member has the following approval rights a election or appointment of Directors and Officers of the Board of Directors b removal of Directors and Officers of the Board of Directors including any executive officer of the corporation c approval of all long-range and short-range plans proposed by the Board of Directors d approval of the annual capital and operating budgets proposed by the Board of Directors e approval of the borrowing of funds where the amount borrowed is in excess of Five Hundred Thousand Dollars 500,000 f approval of the sale, lease, exchange, mortgage, pledge or disposal of all or substantially all of the property and assets g approval of all amendments to or repeal of the Agreement Association or the Bylaws of the corporation h all other rights and powers as specified in the Washington Nonprofit Corporation Act.
Form 990, Part VI, Section B, Line 11b	The VMHS Audit and Compliance Committee ACC, a committee composed of independent community members has been delegated responsibility for oversight of the annual Form 990 preparation process including a selection, engagement, and review of the performance of the independent tax preparer b review of the annual draft Form 990 tax return, and c recommendation of the final Form 990 tax return for review to the BRI Board of Directors. Annually, at the September meeting, management and the tax preparer provides the ACC with an initial draft of the Form 990 and present an overview of the Form 990 preparation process. The final draft Form 990 is reviewed and approved by the ACC in November followed by a Board review of the final Form 990 prior to filing. The final Form 990 tax return is provided to each member of the Board of Directors via electronic delivery.
Form 990, Part VI, Section B, Line 12c	The VMHS Governance Committee has been delegated accountability for oversight of the process for disclosure, evaluation and management of conflict of interest involving any member of the BRI Board of Directors, executive leadership or key employees Covered Person. Pursuant to the Conflict of Interest Policy, an annual conflict of interest questionnaire is distributed to all Covered Persons. In addition, a Covered Person has an on-going duty to disclose the existence of a conflict of interest at any time an actual or potential conflict arises. Each Covered Person is required upon appointment and annually thereafter to attest to a statement that affirms that such person has a received a copy of the Conflict of Interest Policy b has read and understands the Policy c has agreed to comply with the Policy and d understands that BRI is a charitable organization and that in order to maintain its federal tax exemption must engage in activities that accomplish its tax-exempt purposes. Written disclosures are reviewed by the Governance Committee to determine if an actual or potential conflict of interest exists and if so, how it should be managed. The Covered Person is informed in writing regarding the determination the Conflict of Interest Management Plan. No Covered Person with an actual or potential conflict of interest shall engage in an activity on BRIs behalf related to the disclosed actual or potential Conflict of Interest unless such activity is permitted by the Conflict of Interest Management Plan or until the Covered Person has undertaken all steps set forth in the Management Plan to manage, reduce or eliminate the conflict. All Covered Persons have a duty to disclose the existence of any actual or potential conflict of interest with respect to meeting agenda items. The Conflict of Interest Policy requires that copies of the Conflict of Interest Questionnaire be completed annually by each covered Person and any Conflict of Interest Management Plan be maintained.
Form 990, Part VI, Section B, Line 15	The VMHS Compensation and Benefits Board Committee, a committee composed solely of independent directors none of whom have a conflict of interest, is accountable for setting reasonable total compensation packages for each executive, officer and key employee of BRI Executives consistent with BRIs compensation philosophy and principles. The Committee approves annual goals and performance criteria which are used in determining merit increases and variable compensation opportunities. The Committee assesses performance against these goals. The Committee selects and engages a qualified independent compensation consultant to review and analyze the total compensation and benefits packages of the Executives. The Committee as part of its analysis obtains from the compensation consultant appropriate comparability data including total compensation paid by similarly situated organizations for positions that are functionally comparable to each of the Executives. The Committee will consider the significant terms of the agreement with each Executive including the total compensation to be paid and the employees duties and responsibilities. Consistent with the compensation philosophy and principles, the Committee approves total compensation packages for each of the Executives based on information presented to the Committee, reasonableness and the best interest of BRI. The Committees decisions regarding compensation for each Executive are documented in written resolutions and minutes of the Committee. The Committee promptly reports its actions to the VMHS board which reports are reflected in the Boards minutes. The individual positions who were reviewed in 2016 were the Board Director, Carla Greenbaum, BRI Director, and Executive Director and Chief Financial Officer.
Form 990, Part VI, Section C, Line 19	The organizations Articles, Bylaws, Conflict of Interest Policy and financial statements are made available upon request.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (4 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	EINEIN	Primary ActivitiesPrimaryActivitiesTxt	Legal Domicile StateLegalDomicileStateCd	Exempt Code SectionExemptCodeSectionTxt	Public Charity StatusPublicCharityStatusTxt	Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt	Controlled OrganizationControlledOrganizationInd
Virginia Mason Health Sysstem (VMHS)
1100 Ninth Ave	Seattle	WA	98101	911351110	Fundraising	WA	Sec 501c3	7	NA	Yes (true)
Virginia Mason Medical Center
1100 Ninth Ave	Seattle	WA	98101	910565539	Health Care	WA	Sec 501c3	3	VMHS	false
Virginia Mason Institute
1100 Ninth Ave	Seattle	WA	98101	263763656	Education/Research	WA	Sec 501c3	9	VMMC	false
Yakima Valley Memorial Hospital Association
2811 Tieton Drive	Yakima	WA	98902	910567263	Health Care	WA	Sec 501c3	3	VMHS	false

Field	Value	IRS element (for citing)
Receipt Of Int Annts Rnts Rylts	false	ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org	false	GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org	Yes (true)	GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org	false	LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org	false	LoansOrGuaranteesFromOthOrgInd
Div Related Organization	false	DivRelatedOrganizationInd
Asset Sale To Other Org	false	AssetSaleToOtherOrgInd
Asset Purchase From Other Org	false	AssetPurchaseFromOtherOrgInd
Asset Exchange	false	AssetExchangeInd
Rental Of Facilities To Oth Org	Yes (true)	RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org	Yes (true)	RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org	false	PerformOfServicesForOthOrgInd
Perform Of Services By Other Org	false	PerformOfServicesByOtherOrgInd
Sharing Of Facilities	Yes (true)	SharingOfFacilitiesInd
Paid Employees Sharing	false	PaidEmployeesSharingInd
Reimbursement Paid To Other Org	Yes (true)	ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org	Yes (true)	ReimbursementPaidByOtherOrgInd
Transfer To Other Org	false	TransferToOtherOrgInd
Transfer From Other Org	false	TransferFromOtherOrgInd

Affiliated Group Schedule AffiliatedGroupSchedule

Affiliated Schedule AffiliatedScheduleGrp (5 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	EINEIN	Total Grassroots LobbyTotalGrassrootsLobbyAmt	Total Direct LobbyTotalDirectLobbyAmt	Total Lobby ExpenditureTotalLobbyExpenditureAmt	Other Exempt Purpose ExpendOtherExemptPurposeExpendAmt	Total Exempt Purpose ExpendTotalExemptPurposeExpendAmt	Lobby NontxLobbyNontxAmt	Grassroots NontxGrassrootsNontxAmt	Total Lobby Grssroot Mns NontxTotalLobbyGrssrootMnsNontxAmt	Tot Lbby Expend Mns Lobby NontxTotLbbyExpendMnsLobbyNontxAmt	Share Excess Lobby ExpendShareExcessLobbyExpendAmt	Electing OrganizationElectingOrganizationInd
Benaroya Research Institute at Virginia Mason
1201 Ninth Avenue	Seattle	WA	98101	910653422	$0	$0	$0	$74,957,334	$74,957,334	$49,832	$12,458	$0	$0	$0
Virginia Mason Health System
1100 Ninth Avenue	Seattle	WA	98101	911351110	$0	$0	$0	$21,623,749	$21,623,749	$14,375	$3,594	$0	$0	$0
Virginia Mason Medical Center
1100 Ninth Avenue	Seattle	WA	98101	910565539	$121,040	$52,648	$173,688	$984,139,233	$984,312,921	$654,371	$163,593	$0	$0	$0	Yes (X)
Virginia Mason Institute
1100 Ninth Avenue	Seattle	WA	98101	263763856	$0	$0	$0	$7,100,623	$7,100,623	$4,720	$1,180	$0	$0	$0
Yakima Valley Memorial Hospital Association
2811 Tieton Drive	Yakima	WA	98902	910567263	$42,094	$60,000	$102,094	$416,114,779	$416,216,873	$276,701	$69,175	$0	$0	$0